These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles. Labala S; Jose A; Chawla SR; Khan MS; Bhatnagar S; Kulkarni OP; Venuganti VVK Int J Pharm; 2017 Jun; 525(2):407-417. PubMed ID: 28373100 [TBL] [Abstract][Full Text] [Related]
4. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing. Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656 [TBL] [Abstract][Full Text] [Related]
5. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646 [TBL] [Abstract][Full Text] [Related]
6. Functionalized LbL Film for Localized Delivery of STAT3 siRNA and Oxaliplatin Combination to Treat Colon Cancer. Janardhanam LSL; Bandi SP; Venuganti VVK ACS Appl Mater Interfaces; 2022 Mar; 14(8):10030-10046. PubMed ID: 35170934 [TBL] [Abstract][Full Text] [Related]
7. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes. Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. Jose A; Labala S; Venuganti VV J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148 [TBL] [Abstract][Full Text] [Related]
9. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Pan J; Ruan W; Qin M; Long Y; Wan T; Yu K; Zhai Y; Wu C; Xu Y Sci Rep; 2018 Jan; 8(1):1117. PubMed ID: 29348670 [TBL] [Abstract][Full Text] [Related]
10. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439 [TBL] [Abstract][Full Text] [Related]
11. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles. Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608 [TBL] [Abstract][Full Text] [Related]
12. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection. Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335 [TBL] [Abstract][Full Text] [Related]
13. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice. Bastaki S; Aravindhan S; Ahmadpour Saheb N; Afsari Kashani M; Evgenievich Dorofeev A; Karoon Kiani F; Jahandideh H; Beigi Dargani F; Aksoun M; Nikkhoo A; Masjedi A; Mahmoodpoor A; Ahmadi M; Dolati S; Namvar Aghdash S; Jadidi-Niaragh F Life Sci; 2021 Feb; 266():118847. PubMed ID: 33309720 [TBL] [Abstract][Full Text] [Related]
14. Chitosan/siRNA functionalized titanium surface via a layer-by-layer approach for in vitro sustained gene silencing and osteogenic promotion. Song W; Song X; Yang C; Gao S; Klausen LH; Zhang Y; Dong M; Kjems J Int J Nanomedicine; 2015; 10():2335-46. PubMed ID: 25848254 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of sulfonated chitosan-modified gold nanoparticles and their surface electronic payload of charged drugs. Wang H; He J; Ding Y; Xia X Sci China Life Sci; 2018 Apr; 61(4):457-463. PubMed ID: 29656337 [TBL] [Abstract][Full Text] [Related]
16. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response. Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176 [TBL] [Abstract][Full Text] [Related]
17. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544 [TBL] [Abstract][Full Text] [Related]
18. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908 [TBL] [Abstract][Full Text] [Related]
19. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis. Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789 [TBL] [Abstract][Full Text] [Related]
20. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo. Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]